Prelude Capital Management, LLC Idexx Laboratories Inc Transaction History

Prelude Capital Management, LLC

$1.5 Billion
Q4 2024

A detailed history of Prelude Capital Management, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 557 shares of IDXX stock, worth $243,470. This represents 0.02% of its overall portfolio holdings.

Number of Shares

557

Previous 430 29.53%

Holding current value

$243,470

Previous $217,000 5.99%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$406.92 - $495.42 $51,678 - $62,918	127 Added 29.53%	557 $230,000
Q3 2024 Nov 14, 2024	SELL	$455.08 - $517.19 $208,426 - $236,873	-458 Reduced 51.58%	430 $217,000
Q2 2024 Aug 14, 2024	SELL	$468.04 - $548.53 $190,960 - $223,800	-408 Reduced 31.48%	888 $432,000
Q1 2024 May 15, 2024	BUY	$515.08 - $576.87 $667,543 - $747,623	1,296 New	1,296 $699,000
Q3 2023 Nov 14, 2023	BUY	$432.42 - $556.67 $779,220 - $1 Million	1,802 Added 266.96%	2,477 $1.08 Million
Q2 2023 Aug 14, 2023	SELL	$450.7 - $503.61 $29,746 - $33,238	-66 Reduced 8.91%	675 $339,000
Q1 2023 May 15, 2023	SELL	$406.01 - $514.59 $1.3 Million - $1.64 Million	-3,195 Reduced 81.17%	741 $370,000
Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $892,760 - $1.21 Million	2,750 Added 231.87%	3,936 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$325.8 - $407.78 $386,398 - $483,627	1,186 New	1,186 $386,000
Q2 2021 Aug 16, 2021	SELL	$486.36 - $637.08 $282,575 - $370,143	-581 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$465.18 - $551.79 $270,269 - $320,589	581 New	581 $284,000
Q3 2020 Nov 16, 2020	SELL	$334.54 - $406.31 $571,728 - $694,383	-1,709 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$230.66 - $330.16 $394,197 - $564,243	1,709 New	1,709 $564,000
Q4 2019 Feb 14, 2020	SELL	$248.66 - $285.01 $30,336 - $34,771	-122 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$260.07 - $289.93 $18,985 - $21,164	73 Added 148.98%	122 $33,000
Q2 2019 Aug 14, 2019	SELL	$215.53 - $275.33 $18,966 - $24,229	-88 Reduced 64.23%	49 $13,000
Q1 2019 May 15, 2019	SELL	$178.02 - $225.69 $18,692 - $23,697	-105 Reduced 43.39%	137 $31,000
Q4 2018 Feb 14, 2019	SELL	$176.18 - $248.92 $396,228 - $559,821	-2,249 Reduced 90.29%	242 $45,000
Q3 2018 Nov 14, 2018	BUY	$218.82 - $254.46 $25,601 - $29,771	117 Added 4.93%	2,491 $622,000
Q2 2018 Aug 14, 2018	BUY	$185.56 - $227.9 $301,163 - $369,881	1,623 Added 216.11%	2,374 $517,000
Q1 2018 May 15, 2018	BUY	$157.81 - $204.73 $32,824 - $42,583	208 Added 38.31%	751 $144,000
Q4 2017 Feb 14, 2018	SELL	$147.68 - $168.37 $54,346 - $61,960	-368 Reduced 40.4%	543 $85,000
Q3 2017 Nov 14, 2017	BUY	$150.32 - $166.46 $136,941 - $151,645	911	911 $142,000

Others Institutions Holding IDXX

# of Institutions

1,224

Shares Held

73.5M

Call Options Held

151K

Put Options Held

312K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $36.4B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Idexx Laboratories Inc Transaction History